Literature DB >> 25791224

Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?

Antonio Palasí1, Belén Gutiérrez-Iglesias, Montse Alegret, Francesc Pujadas, Mikel Olabarrieta, Diana Liébana, Manolo Quintana, José Álvarez-Sabín, Mercè Boada.   

Abstract

Early-onset and late-onset Alzheimer's disease (EOAD and LOAD) are two forms of the disease with the same characteristic neuropathological hallmarks. However, higher burdens of neuritic plaques and neurofibrillary tangles in frontal and parietal lobes have been found in EOAD than in LOAD patients. Thus, the EOAD subjects may have a differentiated clinical presentation compared to the LOAD ones. Some authors have found less hippocampal memory presentations and more focal cortical abnormalities (such as visuoconstructive or executive dysfunction) in EOAD than LOAD patients. The aim of the present study was to determine which initial clinical profiles differ between EOAD and LOAD; and to analyze whether another age cut-off could discriminate better between EOAD and LOAD clinical presentations than the conventional limit of 65. All patients fulfilling NINCDS-ADRDA criteria for probable Alzheimer's disease who referred to our Hospital between October 2007 and December 2012 were included in the study. The conventional age limit of 65 was established to distinguish between EOAD and LOAD. Baseline neuropsychological scores, adjusted for age and education, were compared between both groups. A total of 181 patients (38 EOAD, 143 LOAD) entered in the analysis. Sex distribution and time of evolution of symptoms did not differ between groups. The EOAD patients performed worse than LOAD in attentional, imitation praxis and verbal learning tests. In addition, the age cut-off of 70 was found to differentiate between early- and late-onset groups better than the standard cut-off of 65 years old. Our results support a differentiated neuropsychological impairment pattern in EOAD compared to LOAD.

Entities:  

Mesh:

Year:  2015        PMID: 25791224     DOI: 10.1007/s00415-015-7698-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  49 in total

1.  Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.

Authors:  Lieke L Smits; Yolande A L Pijnenburg; Esther L G E Koedam; Annelies E van der Vlies; Ilona E W Reuling; Teddy Koene; Charlotte E Teunissen; Philip Scheltens; Wiesje M van der Flier
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

3.  Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease.

Authors:  S J Ross; N Graham; L Stuart-Green; M Prins; J Xuereb; K Patterson; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

4.  Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.

Authors:  Johanna Lind; Anne Larsson; Jonas Persson; Martin Ingvar; Lars-Göran Nilsson; Lars Bäckman; Rolf Adolfsson; Marc Cruts; Kristel Sleegers; Christine Van Broeckhoven; Lars Nyberg
Journal:  Neurosci Lett       Date:  2006-01-06       Impact factor: 3.046

5.  The topography of grey matter involvement in early and late onset Alzheimer's disease.

Authors:  Giovanni B Frisoni; Michela Pievani; Cristina Testa; Francesca Sabattoli; Lorena Bresciani; Matteo Bonetti; Alberto Beltramello; Kiralee M Hayashi; Arthur W Toga; Paul M Thompson
Journal:  Brain       Date:  2007-02-09       Impact factor: 13.501

6.  Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type.

Authors:  C L Grady; J V Haxby; B Horwitz; G Berg; S I Rapoport
Journal:  Neuropsychologia       Date:  1987       Impact factor: 3.139

7.  Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease.

Authors:  Christiane Möller; Hugo Vrenken; Lize Jiskoot; Adriaan Versteeg; Frederik Barkhof; Philip Scheltens; Wiesje M van der Flier
Journal:  Neurobiol Aging       Date:  2013-04-03       Impact factor: 4.673

8.  Neuropsychologic features of early- and late-onset Alzheimer's disease.

Authors:  C M Filley; J Kelly; R K Heaton
Journal:  Arch Neurol       Date:  1986-06

Review 9.  A clinical approach to early-onset inheritable dementia.

Authors:  Brian S Rogers; Carol F Lippa
Journal:  Am J Alzheimers Dis Other Demen       Date:  2012-05       Impact factor: 2.035

10.  Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer's disease.

Authors:  Yasutaka Toyota; Manabu Ikeda; Shunichiro Shinagawa; Teruhisa Matsumoto; Naomi Matsumoto; Kazuhiko Hokoishi; Ryuji Fukuhara; Tomohisa Ishikawa; Takaaki Mori; Hiroyoshi Adachi; Kenjiro Komori; Hirotaka Tanabe
Journal:  Int J Geriatr Psychiatry       Date:  2007-09       Impact factor: 3.485

View more
  15 in total

1.  Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.

Authors:  Michio Takahashi; Yasunori Oda; Toshiyuki Okubo; Yukihiko Shirayama
Journal:  J Neural Transm (Vienna)       Date:  2017-05-16       Impact factor: 3.575

Review 2.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

3.  Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.

Authors:  Daniele Altomare; Clarissa Ferrari; Anna Caroli; Samantha Galluzzi; Annapaola Prestia; Wiesje M van der Flier; Rik Ossenkoppele; Bart Van Berckel; Frederik Barkhof; Charlotte E Teunissen; Anders Wall; Stephen F Carter; Michael Schöll; I L Han Choo; Timo Grimmer; Alberto Redolfi; Agneta Nordberg; Philip Scheltens; Alexander Drzezga; Giovanni B Frisoni
Journal:  J Neurol       Date:  2019-07-02       Impact factor: 4.849

4.  Loss of functional heterogeneity along the CA3 transverse axis in aging.

Authors:  Heekyung Lee; Zitong Wang; Arjuna Tillekeratne; Nick Lukish; Vyash Puliyadi; Scott Zeger; Michela Gallagher; James J Knierim
Journal:  Curr Biol       Date:  2022-05-20       Impact factor: 10.900

Review 5.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 6.  Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia? Review of Key Points Toward an Accurate Clinical and Neuropsychological Diagnosis.

Authors:  Gada Musa; Andrea Slachevsky; Carlos Muñoz-Neira; Carolina Méndez-Orellana; Roque Villagra; Christian González-Billault; Agustín Ibáñez; Michael Hornberger; Patricia Lillo
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

7.  Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

Authors:  Jurre den Haan; Jacoba A van de Kreeke; Elles Konijnenberg; Mara Ten Kate; Anouk den Braber; Frederik Barkhof; Bart N van Berckel; Charlotte E Teunissen; Philip Scheltens; Pieter Jelle Visser; Frank D Verbraak; Femke H Bouwman
Journal:  Alzheimers Dement (Amst)       Date:  2019-06-18

8.  Report of a Case of Creutzfeldt-Jakob Disease With an Unusual Clinical Presentation.

Authors:  Elena Prodi; Stefania Rossi; Ilaria Bertaina; Emanuele Pravatà; Leonardo Sacco
Journal:  Front Behav Neurosci       Date:  2020-04-09       Impact factor: 3.558

9.  The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease.

Authors:  Giacomo Tondo; Leonardo Iaccarino; Silvia Paola Caminiti; Luca Presotto; Roberto Santangelo; Sandro Iannaccone; Giuseppe Magnani; Daniela Perani
Journal:  Alzheimers Res Ther       Date:  2020-04-30       Impact factor: 6.982

Review 10.  Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease.

Authors:  Gary P Morris; Ian A Clark; Bryce Vissel
Journal:  Acta Neuropathol       Date:  2018-10-22       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.